Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 4Dermatologic 4Sarcoma 3Thoracic 2Other solid neoplasm 2Gynecologic 2Breast 2Head & Neck 1Gastrointestinal 1Classical hematology 1CNS 1

Conditions

Retinoblastoma 22Unspecified Adult Solid Tumor, Protocol Specific 5Sarcoma 4Medulloblastoma 4Central Nervous System Neoplasms 4Rhabdoid Tumor 3Retinal Neoplasms 3Optic Nerve Glioma 3Neuroblastoma 3Carcinoma, Renal Cell 3Astrocytoma 3Wilms Tumor 2Relapsed Pediatric Solid Tumor 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms 2Melanoma 2Hepatoblastoma 2Familial ependymoma 2Extensive Stage Small Cell Lung Cancer 2Choroid Plexus Neoplasms 2Advanced Solid Tumors 2Uveal Melanoma 1Urologic Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Unresectable Locally Advanced or Metastatic Solid Tumors 1Thyroid Neoplasms 1Thrombocytopenia 1Testicular Neoplasms 1Solid Tumor 1Small Cell Lung Carcinoma 1

Interventions

pembrolizumab 12Nivolumab 6atezolizumab 3Ipilimumab 3tislelizumab 2spartalizumab 2durvalumab 2avelumab 2Etoposide 2ruxolitinib 1poly ICLC 1obinutuzumab 1naptumomab estafenatox 1milademetan 1epacadostat 1enzalutamide 1entinostat 1cemiplimab 1budigalimab 1bemcentinib 1Thrombopoietin 1Sirolimus 1Quality of Life 1Pemetrexed 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Levoleucovorin 1Leucovorin 1LY2940680 1Interleukin-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Melanoma × Etoposide × Other solid neoplasm × Clear all
NCT03420963 2026-03-20

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Terminated
12 enrolled
DermatologicGenitourinaryHead & NeckOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Bone Neoplasms, Endocrine Gland Neoplasms, Melanoma, Mouth Neoplasms, Pharyngeal Neoplasms, Sarcoma, Skin Neoplasms, Thyroid Neoplasms, Urologic Neoplasms

NCT00003597 2014-07-24

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

Children's Oncology Group

Phase 1 Completed
16 enrolled
CNSClassical hematologyDermatologicGenitourinaryGynecologicOther solid neoplasmSarcoma

Uveal Melanoma, Astrocytoma, Carcinoma, Renal Cell, Medulloblastoma, Melanoma, Neoplasms, Wilms Tumor, Neuroblastoma, Neutropenia, Retinoblastoma, Osteosarcoma, Testicular Neoplasms, Thrombocytopenia, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡